XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.23.3

EARNINGS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE The numerator for both basic and diluted earnings per share (EPS) is net income (loss) attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method. The following table is a reconciliation of net income (loss) attributable to Baxter stockholders.
| Three months ended September 30, |  | Nine months ended September 30,
(in millions) | 2023 | 2022 |  | 2023 | 2022
Income (loss) from continuing operations | $ | 51 |  | $ | (2,991) |  |  | $ | (142) |  | $ | (2,798) |
Less: Net income attributable to noncontrolling interests | 3 |  | 3 |  |  | 6 |  | 8 |
Income (loss) from continuing operations attributable to Baxter stockholders | 48 |  | (2,994) |  |  | (148) |  | (2,806) |
Income from discontinued operations | 2,460 |  | 57 |  |  | 2,559 |  | 192 |
Net income (loss) attributable to Baxter stockholders | $ | 2,508 |  | $ | (2,937) |  |  | $ | 2,411 |  | $ | (2,614) |
The following table is a reconciliation of basic shares and diluted shares.
| Three months ended September 30, |  | Nine months ended September 30,
(in millions) | 2023 | 2022 |  | 2023 | 2022
Basic shares | 507 |  | 504 |  |  | 506 |  | 503 |
Effect of dilutive securities | 2 |  | — |  |  | — |  | — |
Diluted shares | 509 |  | 504 |  |  | 506 |  | 503 |
The effect of dilutive securities for the three months ended September 30, 2023 includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. Basic and diluted shares are the same for the three months ended September 30, 2022 and the nine months ended September 30, 2023 and 2022 due to our net losses from continuing operations for those periods. Diluted EPS excludes 18 million and 25 million shares issuable under equity awards for the three and nine months ended September 30, 2023, respectively, and 23 million shares issuable under equity awards for the three and nine months ended September 30, 2022, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration